XML 52 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Equity Incentive Plans (Tables)
9 Months Ended
Oct. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information

A summary of activity under our equity incentive plans and related information is as follows:

 

 

 

Options Outstanding

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise Price

 

 

Weighted-

Average

Remaining

Contractual

Life (In Years)

 

 

Aggregate

Intrinsic

Value (In Thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 31, 2015

 

 

54,284,474

 

 

$

3.02

 

 

 

8.3

 

 

$

523,654

 

Options granted

 

 

18,159,824

 

 

 

15.77

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(1,784,066

)

 

 

2.64

 

 

 

 

 

 

 

 

 

Options cancelled

 

 

(1,730,681

)

 

 

7.09

 

 

 

 

 

 

 

 

 

Balance as of October 31, 2015

 

 

68,929,551

 

 

 

6.29

 

 

 

 

 

 

 

 

 

Vested and exercisable as of October 31, 2015

 

 

21,903,812

 

 

 

1.71

 

 

 

6.8

      

 

$

348,767

 

Vested and expected to vest as of October 31, 2015

 

 

66,851,238

 

 

 

6.22

 

 

 

8.1

 

 

$

763,519

 

 

Summary of Estimated Fair Value of Employee Purchase Plan

We estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2014

 

 

2015

 

 

2014

 

 

2015

 

Expected term (in years)

 

 

 

 

 

0.4 – 1.9

 

 

 

 

 

 

0.4 – 1.9

 

Expected volatility

 

 

 

 

49

%

 

 

 

 

49

%

Risk-free interest rate

 

 

 

 

0.1% - 0.7

%

 

 

 

 

0.1% - 0.7

%

Dividend rate

 

 

 

 

 

 

 

 

 

 

 

 

 

Summarizes the Components of Stock-Based Compensation

The following table summarizes the components of stock-based compensation expense recognized in the condensed consolidated statements of operations (in thousands):

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2014

 

 

2015

 

 

2014

 

 

2015

 

Cost of revenue—product

 

$

35

 

 

$

43

 

 

$

264

 

 

$

139

 

Cost of revenue—support

 

 

159

 

 

 

657

 

 

 

1,057

 

 

 

1,511

 

Research and development

 

 

3,399

 

 

 

8,195

 

 

 

18,546

 

 

 

18,624

 

Sales and marketing

 

 

2,315

 

 

 

4,559

 

 

 

19,676

 

 

 

10,539

 

General and administrative

 

 

823

 

 

 

2,085

 

 

 

5,331

 

 

 

5,385

 

Total stock-based compensation expense

 

$

6,731

 

 

$

15,539

 

 

$

44,874

 

 

$

36,198